Clinical Trial Update: Pharmacokinetic (PK) and Safety Study of Meropenem in Young Infants With Intra-abdominal Infections [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 pharmacokinetic and safety study of meropenem in young infants with intra-abdominal infections has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intra-abdominal Infection
• Necrotizing Enterocolitis

Drugs mentioned

• Meropenem (Meropenem)

Snippet

Sponsor: The Emmes Company, LLC | Conditions: Necrotizing Enterocolitis, Intra-abdominal Infection | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2011-11-29